Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/17/2025

Long-Term Health Risks for Women with Gestational Diabetes

Primary Risk: Type 2 Diabetes

  • Women with gestational diabetes have a 10-fold increased risk of developing type 2 diabetes compared to women without gestational diabetes, with a lifetime risk of 50-60% 1
  • The risk of developing type 2 diabetes follows a linear progression throughout life, with approximately 20% at 10 years, 30% at 20 years, 40% at 30 years, 50% at 40 years, and 60% at 50 years after the gestational diabetes pregnancy 1
  • Published studies demonstrate that 35-60% of women develop type 2 diabetes within 10 years after gestational diabetes 2

Cardiovascular Disease Risk

  • Women with gestational diabetes share characteristics with metabolic syndrome, including glucose intolerance, insulin resistance, central obesity, elevated triglycerides, and low HDL cholesterol 2
  • Evidence suggests that short-term endothelial dysfunction during late pregnancy manifests as transient hypertension, with long-term endothelial dysfunction associated with chronic hypertension and cardiovascular disease 2
  • Chronic insulin resistance may produce chronic inflammation, adversely affecting vascular reactivity and atherogenesis 2

Additional Long-Term Risks

  • Women with gestational diabetes have an increased risk of impaired glucose tolerance and type 1 diabetes, with markers of islet cell-directed autoimmunity associated with increased risk 2
  • There is an increased risk of chronic hypertension later in life 2

Critical Follow-Up Requirements

  • The American College of Obstetricians and Gynecologists recommends performing a 75-g oral glucose tolerance test at 4-12 weeks after delivery 1
  • Fasting plasma glucose alone has insufficient sensitivity for diagnosing impaired glucose tolerance or type 2 diabetes postpartum, emphasizing the need for oral glucose tolerance testing 2
  • Annual screening with A1C or fasting plasma glucose, and triennial 75-g oral glucose tolerance testing, are recommended for women with a history of gestational diabetes 1

Evidence-Based Prevention Strategies

  • Intensive lifestyle intervention can reduce progression to diabetes by 35% over 10 years, with a number needed to treat of 5-6 individuals to prevent one case of diabetes over 3 years 1
  • Metformin can reduce progression to diabetes by 40% over 10 years in women with prediabetes and a history of gestational diabetes, with a number needed to treat of 5-6 individuals to prevent one case of diabetes over 3 years 1
  • Thiazolidinediones have shown efficacy in preventing progression from impaired glucose tolerance to diabetes 2

Important Clinical Pitfalls

  • Relying solely on fasting glucose misses the majority of women with glucose intolerance 2
  • Progestin-only oral contraceptives and depo medroxyprogesterone acetate are associated with a 2- to 3-fold increase in diabetes risk in Latino populations of breastfeeding women 2
  • Pregnancy planning should include evaluation of glucose tolerance, and if abnormal, treatment of hyperglycemia before discontinuation of contraception 2